Therapeutic targeting and patient selection for cancers with homologous recombination defects.
about
The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts.The Evolution, Functions and Applications of the Breast Cancer Genes BRCA1 and BRCA2.Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers.Novel Strategies on Personalized Medicine for Breast Cancer Treatment: An Update.
P2860
Therapeutic targeting and patient selection for cancers with homologous recombination defects.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Therapeutic targeting and pati ...... ologous recombination defects.
@en
Therapeutic targeting and pati ...... ologous recombination defects.
@nl
type
label
Therapeutic targeting and pati ...... ologous recombination defects.
@en
Therapeutic targeting and pati ...... ologous recombination defects.
@nl
prefLabel
Therapeutic targeting and pati ...... ologous recombination defects.
@en
Therapeutic targeting and pati ...... ologous recombination defects.
@nl
P2093
P2860
P1476
Therapeutic targeting and pati ...... mologous recombination defects
@en
P2093
Francien Talens
Marcel A Van Vugt
Mathilde Jalving
P2860
P304
P356
10.1080/17460441.2017.1322061
P407
P577
2017-05-02T00:00:00Z